Navigation Links
John Theurer Cancer Center researchers shed light on new multiple myeloma therapy
Date:7/25/2012

HACKENSACK, N.J. (July 25, 2012) Researchers from John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, played leading roles in three separate multi-center studies with the new proteasome inhibitor carfilzomib published in Blood, a major peer-reviewed scientific journal.

Carfilzomib is a novel, highly selective proteasome inhibitor, a type of medication that blocks the actions of certain proteins (proteasomes) that cancer cells need to survive and multiply. Carfilzomib is also known by its branded name Kyprolis.

On July 20th the U.S. Food and Drug Administration (FDA) approved Kyprolis (carfilzomib) as a new treatment for advanced multiple myeloma. The treatment was fast-tracked due to the unmet need in multiple myeloma.

The most recent Blood study, published online today, includes results from the open-label, single arm phase IIb 003-A1 study of single-agent carfilzomib for patients with relapsed and refractory multiple myeloma. Carfilzomib's New Drug Application (NDA) is based primarily on this study. This research, along with the two other Blood studies, may change the way multiple myeloma is managed for newly diagnosed and relapsed/refractory patients.

Phase IIb Clinical Trial Published in Blood

David S. Siegel, M.D., Ph.D., Chief, Multiple Myeloma was the lead investigator of this pivotal multi-center, phase IIb study involving 30 cancer centers in the United States and Canada. The trial evaluated 266 heavily-pretreated patients with relapsed and refractory multiple myeloma who had received at least two prior therapies, including bortezomib and either thalidomide or lenalidomide.

"We found that carfilzomib produced clinically significant responses with an acceptable safety profile in heavily pretreated patients with relapsed and refractory multiple myeloma," said Dr. Siegel. "Given the limited number of treatment options
'/>"/>

Contact: Amy Leahing
aleahing@p4strategy.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Experts from John Theurer Cancer Center to participate in the AAMDSIF Patient and Family Conference
2. John Theurer Cancer Center hosting 8th Annual Neuro-Oncology Symposium
3. New probe provides vital assist in brain cancer surgery
4. Researchers find driver of breast cancer stem cell metastasis
5. Novel pig model may be useful for human cancer studies
6. Colonoscopy screening markedly reduces colorectal cancer incidence and death
7. A new route for tackling treatment-resistant prostate cancer
8. Antioxidants Might Help Cut Pancreatic Cancer Risk, Study Suggests
9. Young Cancer Patients Often Lack Support: Study
10. Media alert: 24th EORTC - NCI - AACR Symposium Molecular Targets and Cancer Therapeutics
11. Tel Aviv University research links childhood obesity to cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... New York (PRWEB) May 29, 2015 ... of patented products, announces that it has signed a ... a technology patent that aims to let people learn ... experts in real time. , "This is an exciting ... Room " said Scott J. Cooper, CEO and Creative ...
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 The ... Today, with a circulation of approximately 250,000 and an ... nationally, through a vast social media strategy, and across ... To explore the digital version of the campaign, ... of the print publication. Inside, the actress, model and ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... wellness, as well as a number of specific concerns ... care, stigma reduction and mental health in the workplace. ... about mental health. The campaign also brings special focus ... those individuals to speak up and seek help from ...
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... (HealthDay News) -- Facebook is using its social-networking prowess ... The site is launching a service that will allow ... Facebook using either a special "Report Suicidal Content" link or ... who posted the worrisome comment will immediately receive an email ...
... (HealthDay News) -- Alcohol use by American teens has dropped ... and don,t believe it,s a dangerous drug, according to an ... Drug Abuse and the University of Michigan. The nationally ... 12 at 400 public and private schools found a continuing ...
... capable of halting the devastating mental decline of Alzheimer,s disease, ... PLoS one . When given to mice with ... brain damage caused by the disease. The new compound, developed ... be tested for treatment of the disease in humans in ...
... , WEDNESDAY, Dec. 14 (HealthDay News) -- Decking the ... more dangerous, a new government report finds. In ... treated in U.S. emergency departments for injuries involving holiday ... 2008 and 2009, according to the U.S. Consumer Product ...
... viruses contribute to 15-20% of human cancers worldwide. Kaposi,s ... sarcoma (KS) and two other rare lymphoproliferative malignancies. KS ... and remains a primary cause of cancer deaths in ... AIDS pandemic. Researchers at the Institute of Biotechnology and ...
... from the U.S. Agency for Healthcare Research and ... organizations anticipate, avoid and address problems that can ... The free tool, called the "Unintended Consequences ... and resources. Experts from the RAND Corporation, the ...
Cached Medicine News:Health News:Facebook Launches Service to Help Prevent Suicide 2Health News:Alcohol Use Down, Pot Use Up Among U.S. Teens 2Health News:Alzheimer's drug candidate may be first to prevent disease progression 2Health News:Alzheimer's drug candidate may be first to prevent disease progression 3Health News:Injuries Linked to Holiday Decorating on the Rise 2Health News:Injuries Linked to Holiday Decorating on the Rise 3Health News:KS-herpesvirus induces reprogramming of lymphatic endothelial cells to invasive mesenchymal cells 2Health News:Online guide helps health organizations adopt electronic health records 2
(Date:5/28/2015)... Research and Markets ( ... "United States Medical Adhesives Market Forecast and ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , The ... United States is projected to register ... device manufacturers across the US are expanding their ...
(Date:5/28/2015)... May 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... Therapeutics WebcastWhen: , Thursday, June 4 at 1:00 p.m. ... , Live on the Internet.  Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
(Date:5/28/2015)... Md. , May 28, 2015 ... it will be a supporting organization of the ... and sterilization in 2016. Johnson & ... series of high-profile superbug infections in endoscopes. J&J ... health issues between 1976 and 2003 on advances ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... Science, public health, and regulatory highlights for ... nformation in this document is designed for credentialed journalists. ... April 18, 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... any regulatory or enforcement actions due to legal limitations. ...
... (Nasdaq: LMNX ) today announced that it expects ... Monday, May 9, 2011. A press release announcing the results ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the first quarter ended March 31, 2011, ...
Cached Medicine Technology:FDA News & Notes - Week of April 18, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: